Astrin Biosciences' Certitude blood test for supplemental breast cancer screening is now available to eligible women across ...
Lund University receives $19.4M NIH grant to clinically validate MTBR-tau243 blood test for Alzheimer’s staging and prognosis ...
Roche’s TIB MOLBIOL launches a newborn screening kit for SMA, SCID, and sickle cell disease, designed for use on LightCycler ...
Early data from a new pathology institute in Germany highlight referral patterns, case mix stability, and workload insights ...
A bipartisan Senate bill would require Medicare contractors to review local coverage requests within 60 days and increase ...
A phase III trial ancillary analysis found the Decipher Prostate Test predicts which intermediate-risk prostate cancer ...
Revvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody detection solution ...
Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with consumables and ...
Thermo Fisher Scientific introduces the Nicolet RaptIR X FTIR Microscope, offering optical and infrared analysis for ...
FDA clears Qiagen’s QIAstat-Dx BCID GN Plus AMR Panel, enabling US labs to detect 13 gram-negative pathogens and 18 resistance markers.
The regulatory approvals complete the company’s antiphospholipid syndrome testing portfolio for IgA, IgG, and IgM on its automated multi-analyte platform. Werfen announced that its Aptiva ...
The health system is the first in the Southeast to adopt the 15-minute MeMed BV test into its live emergency workflow after research demonstrated reduced hospitalizations and antibiotic exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results